To further explore the function of endogenous INSL5 in NPC, we utilized a specific siRNA to knockdown endogenous INSL5 expression in two different EBV‐positive cell lines (HNE1‐EBV and CNE2‐EBV). The gene discussed is INSL5; the disease is nasopharyngeal carcinoma.